July 05, 2025 a 08:38 am
LH: Analysts Ratings - Laboratory Corporation of America Holdings
The current analyst ratings for Laboratory Corporation of America Holdings indicate overall positive sentiment, with a strong focus on 'Buy' recommendations. This suggests confidence in the company's growth potential amidst its pivotal role in life sciences. The absence of 'Sell' ratings further enhances the optimistic outlook.
Historical Stock Grades
The latest data as of July 2025 shows a consistent bullish sentiment with analysts predominantly recommending 'Buy'.
| Rating | Number of Recommendations | Score |
|---|---|---|
| Strong Buy | 3 | |
| Buy | 13 | |
| Hold | 4 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
- The number of 'Strong Buy' recommendations has decreased over the past months, indicating some cautiousness among analysts.
- 'Buy' remains the dominant rating, reflecting continued confidence in the company's potential.
- The number of 'Hold' ratings saw a slight increase, suggesting a more balanced view amid potential market uncertainties.
- No 'Sell' or 'Strong Sell' recommendations were recorded, underscoring a lack of negative sentiment.
Percentage Trends
Recent data shows noticeable shifts in analyst ratings, with certain categories experiencing changes in proportion.
- Over the past year, 'Strong Buy' ratings decreased from 20% to approximately 15% of total recommendations.
- Recommendations for 'Buy' increased slightly, maintaining a strong presence overall.
- 'Hold' ratings have moved from 10% to about 20%, reflecting more cautious sentiments regarding moderate growth.
- These shifts could imply a growing perceived retail value or inherent defensive attributes within the sector.
Latest Analyst Recommendations
The latest unchanged recommendations mirror a stable confidence level in the company's market performance.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-06-25 | Equal Weight | Equal Weight | Barclays |
| 2025-06-11 | Overweight | Overweight | Morgan Stanley |
| 2025-05-12 | Buy | Buy | Truist Securities |
| 2025-05-06 | Neutral | Neutral | Piper Sandler |
| 2025-04-30 | Equal Weight | Equal Weight | Barclays |
Analyst Recommendations with Change of Opinion
Several analysts recently revised their views, reflecting alterations in market perspectives or underlying company fundamentals.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-03-04 | Buy | Neutral | Citigroup |
| 2025-01-07 | Outperform | In Line | Evercore ISI Group |
| 2024-10-30 | Buy | Hold | HSBC |
| 2024-03-25 | Buy | Hold | Argus Research |
| 2022-12-12 | Neutral | Buy | Citigroup |
Interpretation
The market sentiment assessment for Laboratory Corporation of America Holdings indicates a generally positive outlook. The stability in 'Buy' recommendations suggests confidence in long-term potential, while the absence of 'Sell' ratings confirms a strong base. Recent upgrades highlight renewed interest. However, a gradual increase in 'Hold' ratings hints at cautiousness following volatile market conditions.
Conclusion
The overview of analyst ratings for Laboratory Corporation of America Holdings shows consistent market positivity with major trends favoring stability and confidence in growth. The increase in 'Hold' ratings may denote a transitional market phase, preparing for potential economic shifts. Investors should consider the current trends and the company's robust position within the life sciences sector when making decisions. This balanced view indicates both opportunities for growth and a need for vigilance amid changing market dynamics.